Solbec Pharmaceuticals has successfully completed the first stage of its Phase 1 clinical trial of its SBP002 compound in the treatment of psoriasis.
05/10/2004 - 22:00
Solbec treatment reaches first milestone
05/10/2004 - 22:00
